Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-12-01T02:24:59.672Z Has data issue: false hasContentIssue false
  • English
  • Français

Fluoxetine treatment of panic disorder: A randomized, placebo-controlled, multi-center trial

Published online by Cambridge University Press:  16 April 2020

D. Michelson ,
R.B. Lydiard ,
M.H. Pollack ,
R. Tamura ,
R. Tepner  and
G. Tollefson
D. Michelson
Affiliation:
Eli Lilly and Company, Indianapolis, 46285Indiana
R.B. Lydiard
Affiliation:
Medical University of South Carolina, Charleston, 29425South Carolina, USA
M.H. Pollack
Affiliation:
Eli Lilly and Company, Indianapolis, 46285Indiana
R. Tamura
Affiliation:
Eli Lilly and Company, Indianapolis, 46285Indiana
R. Tepner
Affiliation:
Eli Lilly and Company, Indianapolis, 46285Indiana
G. Tollefson
Affiliation:
Eli Lilly and Company, Indianapolis, 46285Indiana

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Symposia
Information
European Psychiatry , Volume 13 , Issue S4: Standards of psychiatry - 9th Congress of Association of European Psychiatrists , 1998 , pp. 284s
Copyright
Copyright © European Psychiatric Association 1998
Submit a response

Comments

No Comments have been published for this article.